Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached the initial release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Use the following suggestions to fix the “There is not enough free memory to run this program” error on your Windows computer. The next step is to troubleshoot ...

Currently, Power Automate for desktop supports the use of UI automation in all Java apps and applets for the following Java versions: Java apps: Java version 7 and above. Java applets: Java version 7 ...

AUSTIN, Texas — Nine new businesses have been granted conditional cannabis dispensary licenses as Texas expands its Compassionate Use Program for medical marijuana. The new companies include Central ...

Milan — The European Space Agency has refined its plan for the European Resilience from Space (ERS) program, outlining a €1 billion ($1.15 billion) framework that more directly ties Earth observation, ...

Editor’s Note: The Trump administration has clarified that it will use Section 32 tariff revenue, which typically supports child nutrition programs, to extend funding for WIC during the shutdown — ...

FORT HOOD, Texas — The Army for the first time this week granted 200 soldiers the power to use their military ID card to buy food outside of the dining facility with their meal entitlements. For the ...

FEED will allow Soldiers to use their meal entitlements outside of traditional Army-operated dining facilities for the first time. During the pilot, 200 Soldiers from the 61st Quartermaster Battalion ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...